Ultrack Systems Inc. (OTC: MJLB) Launches “PUR Rx” — A Scalable Digital Healthcare Platform Through Joint Venture with Synergy Health Rx Corp.
Ultrack Systems (OTC: MJLB) has launched PUR Rx, a digital healthcare platform, through a 50/50 joint venture with Synergy Health Rx Corp. The platform aims to revolutionize prescription therapy access in Canada, where the digital health market is projected to reach CAD $4.7 billion by 2026 with 8.3% annual growth.
Ultrack will spearhead marketing and brand development, committing up to $10,000 quarterly in marketing spend through 2025. The venture combines Ultrack's digital expertise with Synergy Health's healthcare infrastructure, targeting 25-30% annual revenue growth over three years through recurring service fees, prescription margins, and third-party partnerships.
Ultrack Systems (OTC: MJLB) ha lanciato PUR Rx, una piattaforma sanitaria digitale, tramite una joint venture al 50/50 con Synergy Health Rx Corp. La piattaforma mira a rivoluzionare l'accesso alla terapia con prescrizione in Canada, dove il mercato della salute digitale è previsto raggiungere 4,7 miliardi di CAD entro il 2026 con una crescita annua dell'8,3%.
Ultrack guiderà il marketing e lo sviluppo del marchio, impegnandosi a investire fino a 10.000 dollari trimestrali in campagne promozionali fino al 2025. La joint venture unisce l'esperienza digitale di Ultrack con l'infrastruttura sanitaria di Synergy Health, puntando a una crescita annuale del fatturato del 25-30% nei prossimi tre anni, attraverso commissioni ricorrenti sui servizi, margini sulle prescrizioni e partnership con terze parti.
Ultrack Systems (OTC: MJLB) ha lanzado PUR Rx, una plataforma digital de salud, mediante una empresa conjunta 50/50 con Synergy Health Rx Corp. La plataforma busca revolucionar el acceso a la terapia con receta en Canadá, donde se proyecta que el mercado de salud digital alcance 4.7 mil millones de CAD para 2026 con un crecimiento anual del 8.3%.
Ultrack liderará el marketing y desarrollo de marca, comprometiéndose a invertir hasta 10,000 dólares trimestrales en publicidad hasta 2025. La empresa conjunta combina la experiencia digital de Ultrack con la infraestructura sanitaria de Synergy Health, apuntando a un crecimiento anual de ingresos del 25-30% durante tres años a través de tarifas recurrentes por servicios, márgenes en recetas y asociaciones con terceros.
Ultrack Systems (OTC: MJLB)는 Synergy Health Rx Corp와의 50/50 합작 투자를 통해 디지털 헬스케어 플랫폼 PUR Rx를 출시했습니다. 이 플랫폼은 캐나다에서 처방 치료 접근 방식을 혁신하는 것을 목표로 하며, 디지털 헬스 시장은 2026년까지 47억 캐나다 달러에 도달하고 연평균 8.3% 성장할 것으로 예상됩니다.
Ultrack은 마케팅 및 브랜드 개발을 주도하며 2025년까지 분기별 최대 1만 달러의 마케팅 비용을 투입할 예정입니다. 이 합작 투자는 Ultrack의 디지털 전문성과 Synergy Health의 의료 인프라를 결합하여, 반복 서비스 수수료, 처방 마진, 제3자 파트너십을 통해 향후 3년간 연간 25~30% 매출 성장을 목표로 합니다.
Ultrack Systems (OTC : MJLB) a lancé PUR Rx, une plateforme de santé numérique, via une coentreprise à 50/50 avec Synergy Health Rx Corp. Cette plateforme vise à révolutionner l'accès aux thérapies sur ordonnance au Canada, où le marché de la santé numérique devrait atteindre 4,7 milliards de dollars canadiens d'ici 2026 avec une croissance annuelle de 8,3%.
Ultrack prendra en charge le marketing et le développement de la marque, s'engageant à investir jusqu'à 10 000 dollars par trimestre en marketing jusqu'en 2025. La coentreprise combine l'expertise digitale d'Ultrack avec l'infrastructure de santé de Synergy Health, visant une croissance annuelle du chiffre d'affaires de 25 à 30% sur trois ans grâce aux frais de services récurrents, aux marges sur les prescriptions et aux partenariats avec des tiers.
Ultrack Systems (OTC: MJLB) hat PUR Rx, eine digitale Gesundheitsplattform, im Rahmen eines 50/50 Joint Ventures mit Synergy Health Rx Corp gestartet. Die Plattform zielt darauf ab, den Zugang zu verschreibungspflichtigen Therapien in Kanada zu revolutionieren, wo der digitale Gesundheitsmarkt bis 2026 voraussichtlich 4,7 Milliarden CAD erreichen wird und ein jährliches Wachstum von 8,3% erwartet wird.
Ultrack wird das Marketing und die Markenentwicklung leiten und sich verpflichten, bis 2025 vierteljährlich bis zu 10.000 USD für Marketing auszugeben. Das Joint Venture verbindet Ultracks digitale Expertise mit der Gesundheitsinfrastruktur von Synergy Health und strebt ein jährliches Umsatzwachstum von 25-30% über drei Jahre durch wiederkehrende Servicegebühren, Rezeptmargen und Partnerschaften mit Dritten an.
- Strategic 50/50 joint venture combining Ultrack's digital expertise with Synergy Health's healthcare infrastructure
- Targeting impressive 25-30% annual revenue growth over next three years
- Operating in growing Canadian digital health market projected to reach CAD $4.7B by 2026
- Built-in revenue streams through recurring service fees, prescription margins, and partnerships
- Lower customer acquisition costs due to Ultrack's digital marketing capabilities
- Limited initial marketing budget of only $10,000 per quarter through 2025
- Currently restricted to Ontario market with pending expansion to other provinces
- Faces competition from established players like WELL Health Technologies and Dialogue Health Technologies
CONCORD, Ontario, June 26, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB) is excited to announce the official launch of PUR Rx, a next-generation digital health platform formed through a 50/50 joint venture with Synergy Health Rx Corp. Designed to transform how Canadians access prescribed therapies, PUR Rx merges digital innovation with trusted medical infrastructure to deliver patient-first care at scale.
With the market for digital health in Canada expected to exceed CAD
“PUR Rx is more than a joint venture—it’s a bold leap forward into the future of digital medicine,” said Reno Calabrigo, CEO of Ultrack Systems Inc. “This initiative perfectly blends our technology and branding strengths with Synergy Health’s healthcare credibility and regulatory footprint.”
Positioned at the Crossroads of Digital Health & Revenue Recurrence
PUR Rx leverages Ultrack’s proven capabilities in digital marketing, smart logistics, and user acquisition to accelerate platform growth and patient enrollment. Simultaneously, Synergy Health Rx contributes licensed infrastructure, prescription fulfillment, and a robust patient network, offering immediate operational scalability and regulatory compliance.
Key Platform Features:
- Virtual care access & real-time eligibility checks
- Prescription management through a licensed network
- Secure portals for patients and providers
- Data-driven marketing funnel to increase LTV (lifetime value) per user
Marketing-Driven Expansion with Ultrack at the Helm
Ultrack will lead the strategic rollout and brand development of PUR Rx through:
- Paid digital campaigns targeting specific therapeutic verticals
- SEO/SEM and geo-targeted outreach across Ontario
- B2C and B2B lead funnels for patient and clinic acquisition
- Investor-focused awareness campaigns and quarterly updates
Ultrack has committed to funding up to
Competitive Advantage: Combining Agility with Compliance
While larger public digital health players like WELL Health Technologies and Dialogue Health Technologies have shown strong investor interest based on revenue growth and SaaS-style healthcare delivery models, PUR Rx differentiates itself through:
- Joint ownership of infrastructure and patient data
- Built-in fulfillment and regulatory compliance
- Lower CAC (customer acquisition cost) due to Ultrack's digital edge
- Agility to pivot into emerging markets or underserved communities
These advantages offer institutional upside and retail investor appeal, especially as digital-first healthcare becomes the new norm post-pandemic.
Financial Outlook: Recurring Revenue, Scalable Model
The PUR Rx venture is targeting
About Ultrack Systems Inc.
Ultrack Systems Inc. (OTC: MJLB) is a technology and logistics innovator focused on digital marketing, smart infrastructure, and operational scale across healthcare, transportation, and enterprise verticals. The company enables growth through turnkey branding systems, digital outreach, and strategic partnerships.
About Synergy Health Rx Corp.
Synergy Health Rx Corp. is a licensed health services provider specializing in prescription management, patient education, and coordinated care delivery across Ontario. Known for its advocacy-first approach, the company brings operational excellence and compliance assurance to PUR Rx.
INVESTOR NOTE:
With healthcare increasingly shifting toward virtual care, tech-enabled prescribing, and personalized patient experiences, MJLB’s launch of PUR Rx marks a high-leverage entry into a multi-billion-dollar, high-retention industry. Investors seeking exposure to the future of healthcare delivery—and the platforms that power it—should be watching Ultrack Systems Inc. closely.
Safe Harbor Statement
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release, including such forward-looking statements.
Investor Contact:
Email: info@ultrack.ca
Web: ultrack.ca, mybetterpets.com X: @UltrackI
FAQ
What is the joint venture structure between Ultrack Systems (MJLB) and Synergy Health Rx Corp?
What is the projected market size for digital health in Canada by 2026?
What are PUR Rx's revenue growth targets?
How much is Ultrack Systems (MJLB) investing in marketing for PUR Rx?
What are the key features of the PUR Rx platform?
